Tracy L McGregor1, Deborah P Jones1, Li Wang2, Ioana Danciu3, Brian C Bridges1, Geoffrey M Fleming1, Jana Shirey-Rice3, Lixin Chen3, Daniel W Byrne2, Sara L Van Driest4. 1. Department of Pediatrics, Vanderbilt University, Nashville, TN. 2. Department of Biostatistics, Vanderbilt University, Nashville, TN. 3. Institute for Clinical and Translational Research, Vanderbilt University, Nashville, TN. 4. Department of Pediatrics, Vanderbilt University, Nashville, TN; Department of Medicine, Vanderbilt University, Nashville, TN. Electronic address: sara.van.driest@vanderbilt.edu.
Abstract
BACKGROUND: Acute kidney injury (AKI) has been characterized in high-risk pediatric hospital inpatients, in whom AKI is frequent and associated with increased mortality, morbidity, and length of stay. The incidence of AKI among patients not requiring intensive care is unknown. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 13,914 noncritical admissions during 2011 and 2012 at our tertiary referral pediatric hospital were evaluated. Patients younger than 28 days or older than 21 years of age or with chronic kidney disease (CKD) were excluded. Admissions with 2 or more serum creatinine measurements were evaluated. FACTORS: Demographic features, laboratory measurements, medication exposures, and length of stay. OUTCOME: AKI defined as increased serum creatinine level in accordance with KDIGO (Kidney Disease: Improving Global Outcomes) criteria. Based on time of admission, time interval requirements were met in 97% of cases, but KDIGO time window criteria were not strictly enforced to allow implementation using clinically obtained data. RESULTS: 2 or more creatinine measurements (one baseline before or during admission and a second during admission) in 2,374 of 13,914 (17%) patients allowed for AKI evaluation. A serum creatinine difference ≥0.3mg/dL or ≥1.5 times baseline was seen in 722 of 2,374 (30%) patients. A minimum of 5% of all noncritical inpatients without CKD in pediatric wards have an episode of AKI during routine hospital admission. LIMITATIONS: Urine output, glomerular filtration rate, and time interval criteria for AKI were not applied secondary to study design and available data. The evaluated cohort was restricted to patients with 2 or more clinically obtained serum creatinine measurements, and baseline creatinine level may have been measured after the AKI episode. CONCLUSIONS: AKI occurs in at least 5% of all noncritically ill hospitalized children, adolescents, and young adults without known CKD. Physicians should increase their awareness of AKI and improve surveillance strategies with serum creatinine measurements in this population so that exacerbating factors such as nephrotoxic medication exposures may be modified as indicated.
BACKGROUND:Acute kidney injury (AKI) has been characterized in high-risk pediatric hospital inpatients, in whom AKI is frequent and associated with increased mortality, morbidity, and length of stay. The incidence of AKI among patients not requiring intensive care is unknown. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 13,914 noncritical admissions during 2011 and 2012 at our tertiary referral pediatric hospital were evaluated. Patients younger than 28 days or older than 21 years of age or with chronic kidney disease (CKD) were excluded. Admissions with 2 or more serum creatinine measurements were evaluated. FACTORS: Demographic features, laboratory measurements, medication exposures, and length of stay. OUTCOME: AKI defined as increased serum creatinine level in accordance with KDIGO (Kidney Disease: Improving Global Outcomes) criteria. Based on time of admission, time interval requirements were met in 97% of cases, but KDIGO time window criteria were not strictly enforced to allow implementation using clinically obtained data. RESULTS: 2 or more creatinine measurements (one baseline before or during admission and a second during admission) in 2,374 of 13,914 (17%) patients allowed for AKI evaluation. A serum creatinine difference ≥0.3mg/dL or ≥1.5 times baseline was seen in 722 of 2,374 (30%) patients. A minimum of 5% of all noncritical inpatients without CKD in pediatric wards have an episode of AKI during routine hospital admission. LIMITATIONS: Urine output, glomerular filtration rate, and time interval criteria for AKI were not applied secondary to study design and available data. The evaluated cohort was restricted to patients with 2 or more clinically obtained serum creatinine measurements, and baseline creatinine level may have been measured after the AKI episode. CONCLUSIONS: AKI occurs in at least 5% of all noncritically ill hospitalized children, adolescents, and young adults without known CKD. Physicians should increase their awareness of AKI and improve surveillance strategies with serum creatinine measurements in this population so that exacerbating factors such as nephrotoxic medication exposures may be modified as indicated.
Authors: Daniel J Lex; Roland Tóth; Zsuzsanna Cserép; Stephen I Alexander; Tamás Breuer; Erzsébet Sápi; András Szatmári; Edgár Székely; János Gál; Andrea Székely Journal: Ann Thorac Surg Date: 2013-11-06 Impact factor: 4.330
Authors: Rajit K Basu; Anne Andrews; Catherine Krawczeski; Peter Manning; Derek S Wheeler; Stuart L Goldstein Journal: Pediatr Crit Care Med Date: 2013-06 Impact factor: 3.624
Authors: Cherry Mammen; Abdullah Al Abbas; Peter Skippen; Helen Nadel; Daniel Levine; J P Collet; Douglas G Matsell Journal: Am J Kidney Dis Date: 2011-12-28 Impact factor: 8.860
Authors: Brady S Moffett; Stuart L Goldstein; Michelle Adusei; Julia Kuzin; Princy Mohan; Antonio R Mott Journal: Pediatr Crit Care Med Date: 2011-09 Impact factor: 3.624
Authors: Kevin J Downes; Marepalli B Rao; Laurie Kahill; Hovi Nguyen; John P Clancy; Stuart L Goldstein Journal: J Cyst Fibros Date: 2014-04-06 Impact factor: 5.482
Authors: Rajit K Basu; Michael Zappitelli; Lori Brunner; Yu Wang; Hector R Wong; Lakhmir S Chawla; Derek S Wheeler; Stuart L Goldstein Journal: Kidney Int Date: 2013-09-18 Impact factor: 10.612
Authors: Stuart L Goldstein; Eric Kirkendall; Hovi Nguyen; Joshua K Schaffzin; John Bucuvalas; Tracey Bracke; Michael Seid; Marshall Ashby; Natalie Foertmeyer; Lori Brunner; Anne Lesko; Cynthia Barclay; Carole Lannon; Stephen Muething Journal: Pediatrics Date: 2013-08-12 Impact factor: 7.124
Authors: Erica C Bjornstad; Stephen W Marshall; Amy K Mottl; Keisha Gibson; Yvonne M Golightly; Anthony Charles; Emily W Gower Journal: Pediatr Nephrol Date: 2020-01-29 Impact factor: 3.714
Authors: Jessica Sheehan Tangren; Wan Ahmad Hafiz Wan Md Adnan; Camille E Powe; Jeffrey Ecker; Kate Bramham; Michelle A Hladunewich; Elizabeth Ankers; S Ananth Karumanchi; Ravi Thadhani Journal: Hypertension Date: 2018-06-18 Impact factor: 10.190